Border Management and Fight Against Drugs
Border security and the fight against drug trafficking are major challenges for the five Central Asian countries (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan). Together the multi-annual regional BOMCA and CADAP programmes represent the core of the overall EU strategy and long-term commitment to Central Asia in supporting the security and stability of the region.
The Border Management Programme in Central Asia (BOMCA) is one of the largest EC assistance programmes in Central Asia: EU BOMCA's accumulated budgets in 2003-2014 amount to more than € 33 million. The overall objective of BOMCA is to secure the gradual adoption of modern border management methods in Central Asia with the purpose of enhancing border security and facilitating legal trade and transit. In 2011 the programme started its new phase 8.
The Central Asia Drug Action Programme (CADAP) began in 2001. The main objective of CADAP is to foster a balanced drug policy in Central Asian countries, supporting efforts on drug demand reduction in the region and promoting the gradual adoption of applicable EU and international good practices. EU CADAP's accumulated budgets in 2001-2013 amount to € 20.7 million. The EU is preparing the sixth phase of CADAP for implementation to start in 2013 with an estimated budget of € 5 million.
The programme is developed in line with the EU Drug Strategy (2007-2012) and EU Central Asia Drug Action Plan (2009-2013) in “preventing and reducing drug use, dependence, and drug-related harms to health and society”.
Both BOMCA and CADAP have Regional Headquarters located in Bishkek, Kyrgyzstan and have Country Offices in each of the five Central Asian countries. Both programmes coordinate with a wide range of international partners such as UNODC, OSCE, IOM, ADB, USAID, GIZ and other actors involved in border management and drug demand and supply control actions.
More information on BOMCA.
More information on CADAP.